Laura Lunde
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- Polyomavirus and related diseases
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 6
- Hematopoietic Stem Cell Transplantation 1
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Polyomavirus and related diseases 1
- Co-authors
- Mary McKenney (7 shared papers)Nikhil C. Munshi (7 shared papers)Paul G. Richardson (7 shared papers)Teru Hideshima (6 shared papers)Kenneth C. Anderson (7 shared papers)Robert Knight (5 shared papers)Sundar Jagannath (5 shared papers)Amitabha Mazumder (4 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (1 paper)American Journal of Hematology (1 paper)Bone Marrow Transplantation (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- United States
In The Last Decade
Laura Lunde
9 papers receiving 310 citations
Peers
Comparison fields: 5 of 38
- Hematology 247
- Oncology 163
- Molecular Biology 184
- Genetics 20
- Internal Medicine 5
Countries citing papers authored by Laura Lunde
This map shows the geographic impact of Laura Lunde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Lunde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Lunde more than expected).
Fields of papers citing papers by Laura Lunde
This network shows the impact of papers produced by Laura Lunde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Lunde. The network helps show where Laura Lunde may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Lunde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 126 | |
| 2 | 2015 | 79 | |
| 3 | 2005 | 28 | |
| 4 | 2008 | 26 | |
| 5 | 2007 | 22 | |
| 6 | 2010 | 21 | |
| 7 | 2012 | 9 | |
| 8 | 2004 | 6 | |
| 9 | 2012 | 4 |
About Laura Lunde
Laura Lunde is a scholar working on Hematology, Oncology, Molecular Biology, Organic Chemistry and Epidemiology, having authored 9 papers that have together received 321 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (4 papers), Cancer Treatment and Pharmacology (3 papers), Histone Deacetylase Inhibitors Research (1 paper), Polyomavirus and related diseases (1 paper), Quinazolinone synthesis and applications (1 paper), Cancer therapeutics and mechanisms (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Hematology (247 citations), Oncology (163 citations), Molecular Biology (184 citations), Genetics (20 citations) and Internal Medicine (5 citations). Laura Lunde has collaborated with scholars based in United States. Frequent co-authors include Mary McKenney, Nikhil C. Munshi, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson, Robert Knight, Sundar Jagannath, Amitabha Mazumder, Irene M. Ghobrial and Melissa Alsina. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Bone Marrow Transplantation and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.